Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1061)
  3. Review (108)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2470)
  2. Solid Tumor Oncology Division (1885)
  3. Hematologic Malignancies, Division of (1191)
  4. GSK Faculty (1125)
  5. Department of Pathology and Laboratory Medicine (917)
  6. Epidemiology and Biostatistics (863)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (173)
  5. David Solit (166)
  6. Maria Carlo (166)

More People

Years
  1. 2025 (152)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (547)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (82)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (618)
  2. Elsevier Inc. (355)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (177)
  6. Oxford University Press (147)

More Publishers

Results (2567)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1/2 dose expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with ER+ metastatic breast cancer
    Meeting Abstract

    Rosen, E.; Sharma, M.; Berz, D.; Caswell-Jin, J. L.; Spira, A. I.; Fulgar, G. A.; Densel, M.; Rana, N.; Sperry, S.; Warner, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world (RW) outcomes of patients (pts) with advanced breast cancer (aBC) with and without resistance alterations (alts) detected in cell-free circulating tumor DNA (ctDNA) prior to CDK4/6 inhibitor (CDK4/6i) plus endocrine therapy (ET) treatment
    Meeting Abstract

    Wander, S. A.; Weipert, C. M.; Liao, J.; Safonov, A.; Zhang, N.; Bardia, A.; Razavi, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers
    Meeting Abstract

    Drago, J. Z.; Pareja, F.; Jhaveri, K. L.; Walsh, E. M.; Ku, G. Y.; Maron, S. B.; Janjigian, Y. Y.; Robson, M. E.; Reis-Filho, J. S.; Modi, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes with adjuvant nonsteroidal aromatase inhibitors (NSAIs) vs tamoxifen (TAM) in patients with hormone receptor−positive/human epidermal growth factor receptor 2−negative (HR+/HER2−) early breast cancer (EBC): A US database analysis
    Meeting Abstract

    Graff, S. L.; Tolaney, S. M.; Hart, L.L.; Razavi, P.; Fasching, P.A.; Janni, W.; Schwartzberg, L. S.; Lanoue, B.; Romero Salas, T.; Khakwani, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Goal-focused emotion-regulation therapy (GET) in young adult testicular cancer survivors: A randomized pilot study
    Journal Article

    Hoyt, M. A.; Wang, A. W. T.; Ceja, R. C.; Cheavens, J. S.; Daneshvar, M. A.; Feldman, D. R.; Funt, S. A.; Nelson, C. J.
    Annals of Behavioral Medicine (2023)

    Fulltext@MSK | Save
  • Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Lenalidomide-associated B-cell ALL: Clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
    Journal Article

    Geyer, M. B.; Shaffer, B. C.; Bhatnagar, B.; Mims, A. S.; Klein, V.; Dilip, D.; Glass, J. L.; Lozanski, G.; Hassoun, H.; Landau, H.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Diversity, equity, and inclusion in the melanoma research community
    Research Letter

    Portuallo, M. E.; Lu, D. Y.; Alicea, G. M.; Bolling, J.; Lee, R.; McQuade, J.; Warner, A. B.; Davies, M.; Weeraratna, A.; Villanueva, J.; more...
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Clinical benefit from immunotherapy in patients with SCLC is associated with tumor capacity for antigen presentation
    Journal Article

    Rudin, C. M.; Balli, D.; Lai, W. V.; Richards, A. L.; Nguyen, E.; Egger, J. V.; Choudhury, N. J.; Sen, T.; Chow, A.; Poirier, J. T.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save